Israel
Rekah Pharmaceutical Industries Ltd. is a public Israeli generic pharma company established in 1941. The company focuses on manufacturing, marketing, sales, and distribution of pharmaceuticals, dermo-cosmetics, and vitamins. Rekah offers a wide range of approximately 250 Rx & OTC products in various therapeutic areas, including sterile solutions, tablets, liquids, creams, and powders. They cater to the health care, health and wellness, manufacturing, and pharmaceutical industries.
Overall, with its extensive product portfolio and longstanding presence in the industry, Rekah Pharmaceutical Industries Ltd. presents an established player in the pharmaceutical market. While their recent investment details are not available, the company's broad product range and comprehensive market coverage provide a strong foundation for potential investors to consider.
